{
    "2019-04-28": [
        [
            {
                "time": "",
                "original_text": "2018年全球药企25强名单公布 仅1家中国药企上榜",
                "features": {
                    "keywords": [
                        "全球药企",
                        "25强",
                        "中国药企",
                        "上榜"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：继续推荐3+2主线 荐2股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "推荐",
                        "投资主线",
                        "股票"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：医药生物业周报 荐6股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "医药生物",
                        "周报",
                        "推荐"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "成功卡位医药产业链 业绩旱涝保收 超级大牛股底部冉冉起航",
                "features": {
                    "keywords": [
                        "医药产业链",
                        "业绩",
                        "大牛股",
                        "起航"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "2018年全球制药公司25强发布 中国公司上榜",
                "features": {
                    "keywords": [
                        "全球制药",
                        "25强",
                        "中国公司",
                        "上榜"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "全球上市制药公司25强排名公布，中国药企上榜！",
                "features": {
                    "keywords": [
                        "全球制药",
                        "25强",
                        "中国药企",
                        "排名"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【国盛医药张金洋团队】详解2019Q1机构医药持仓，继续推荐医药流通",
                "features": {
                    "keywords": [
                        "国盛医药",
                        "机构持仓",
                        "医药流通",
                        "推荐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药流通"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}